Acadia Healthcare (NASDAQ:ACHC) Stock Price Down 20.5% – Time to Sell?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price dropped 20.5% on Thursday . The stock traded as low as $24.25 and last traded at $22.4550. Approximately 711,208 shares changed hands during trading, a decline of 80% from the average daily volume of 3,474,513 shares. The stock had previously closed at $28.26.

Acadia Healthcare News Summary

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q1 results topped estimates — Acadia reported $0.37 EPS vs. a $0.28 consensus and revenue of $828.8M (up 7.6% YoY), showing underlying growth that supports the recovery thesis. Acadia Healthcare (ACHC) Q1 Earnings and Revenues Beat Estimates
• Positive Sentiment: Company reiterated / raised forward revenue posture in its Q1 release and commentary, signaling management confidence in demand recovery. Acadia Healthcare Posts Q1 2026 Revenue Growth, Raises Outlook
• Positive Sentiment: Unusually large call?option buying was observed (3,427 calls, +112% vs. average), indicating speculative bullish positioning that can amplify intraday gains.
• Neutral Sentiment: Earnings materials and the conference?call transcript provide more detail on margins, facility mix and M&A posture — useful for assessing whether growth is sustainable. Q1 2026 Earnings Call Transcript Q1 Results Presentation
• Negative Sentiment: Q2 guidance disappointed the Street — management set EPS guidance of $0.30–$0.40 (consensus ~ $0.46) and revenue guidance below estimates ($835M–$850M vs. ~$867M consensus), driving sell?the?news reactions and raising near?term execution risk. Acadia Healthcare (ACHC) stock trades down, here is why
• Negative Sentiment: Analyst skepticism and selling pressure followed the post?earnings reaction — at least one noted investor piece recommends selling/downgrade, which can reinforce downward momentum if other funds follow. Why I Am Selling The Rally (Rating Downgrade)
• Negative Sentiment: Local/regional coverage noted the stock dipped after the report despite healthy fundamentals, reflecting short?term investor focus on guidance and margins. Acadia stock slumps despite health Q1 report

Analysts Set New Price Targets

ACHC has been the subject of several analyst reports. Jefferies Financial Group restated a “hold” rating and set a $24.50 price target on shares of Acadia Healthcare in a report on Monday, April 20th. Guggenheim reduced their price target on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a report on Monday, February 23rd. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Leerink Partners raised their price target on Acadia Healthcare from $14.00 to $22.00 and gave the company a “market perform” rating in a report on Thursday, February 26th. Finally, UBS Group raised their price target on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a report on Friday, April 17th. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $24.04.

Acadia Healthcare Price Performance

The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.55. The company has a market capitalization of $2.56 billion, a PE ratio of -2.28, a PEG ratio of 8.75 and a beta of 0.71. The firm has a 50-day moving average of $24.43 and a 200 day moving average of $19.20.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. During the same period last year, the firm posted $0.40 earnings per share. Acadia Healthcare’s revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. As a group, research analysts anticipate that Acadia Healthcare Company, Inc. will post 1.48 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

Several institutional investors have recently modified their holdings of the business. Fifth Third Bancorp boosted its position in shares of Acadia Healthcare by 11,144.0% during the first quarter. Fifth Third Bancorp now owns 25,299 shares of the company’s stock valued at $592,000 after buying an additional 25,074 shares during the last quarter. Sequoia Financial Advisors LLC bought a new position in Acadia Healthcare in the first quarter valued at about $345,000. ARGA Investment Management LP lifted its holdings in Acadia Healthcare by 29.7% in the first quarter. ARGA Investment Management LP now owns 57,098 shares of the company’s stock valued at $1,336,000 after acquiring an additional 13,067 shares during the period. Strs Ohio lifted its holdings in Acadia Healthcare by 15,846.7% in the first quarter. Strs Ohio now owns 347,637 shares of the company’s stock valued at $8,131,000 after acquiring an additional 345,457 shares during the period. Finally, Louisiana State Employees Retirement System bought a new position in Acadia Healthcare in the first quarter valued at about $957,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.